APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alimta

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Alimta Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025179 pages

Choose your research edition.

Industry ResearchAlimta Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Alimta Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Alimta Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alimta Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Alimta Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Alimta market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alimta include Eagle Pharmaceuticals, Eli Lilly, Cadila Healthcare and Abbott Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alimta market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alimta and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alimta sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alimta market size, projected growth trends, production technologies, key applications, and end-use industries.

Alimta Segment by Company

Eagle Pharmaceuticals

Eli Lilly

Cadila Healthcare

Abbott Healthcare

Alimta Segment by Type

100mg

500mg

Alimta Segment by Application

Pleural Mesothelioma

Non-small Cell Lung Cancer

Alimta Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alimta market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alimta and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alimta.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alimta market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alimta manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Alimta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Alimta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Alimta Industry Trends Table 2. Alimta Industry Drivers Table 3. Alimta Industry Opportunities and Challenges Table 4. Alimta Industry Restraints Table 5. Global Alimta Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Alimta Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Alimta Sales by Manufacturers (kg) & (2021-2026) Table 8. Global Alimta Sales Market Share by Manufacturers Table 9. Global Alimta Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Alimta Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Alimta Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Alimta Manufacturers, Product Type & Application Table 13. Global Alimta Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Alimta by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg Table 17. Major Manufacturers of 500mg Table 18. Global Alimta Sales by Type 2021 VS 2025 VS 2032 (kg) Table 19. Global Alimta Sales by Type (2021-2026) & (kg) Table 20. Global Alimta Sales by Type (2027-2032) & (kg) Table 21. Global Alimta Sales Market Share by Type (2021-2026) Table 22. Global Alimta Sales Market Share by Type (2027-2032) Table 23. Global Alimta Revenue by Type 2021 VS 2025 VS 2032 (kg) Table 24. Global Alimta Revenue by Type (2021-2026) & (kg) Table 25. Global Alimta Revenue by Type (2027-2032) & (kg) Table 26. Global Alimta Revenue Market Share by Type (2021-2026) Table 27. Global Alimta Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pleural Mesothelioma Table 29. Major Manufacturers of Non-small Cell Lung Cancer Table 30. Global Alimta Sales by Application 2021 VS 2025 VS 2032 (kg) Table 31. Global Alimta Sales by Application (2021-2026) & (kg) Table 32. Global Alimta Sales by Application (2027-2032) & (kg) Table 33. Global Alimta Sales Market Share by Application (2021-2026) Table 34. Global Alimta Sales Market Share by Application (2027-2032) Table 35. Global Alimta Revenue by Application 2021 VS 2025 VS 2032 (kg) Table 36. Global Alimta Revenue by Application (2021-2026) & (kg) Table 37. Global Alimta Revenue by Application (2027-2032) & (kg) Table 38. Global Alimta Revenue Market Share by Application (2021-2026) Table 39. Global Alimta Revenue Market Share by Application (2027-2032) Table 40. Global Alimta Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 41. Global Alimta Sales by Region (2021-2026) & (kg) Table 42. Global Alimta Sales Market Share by Region (2021-2026) Table 43. Global Alimta Sales Forecasted by Region (2027-2032) & (kg) Table 44. Global Alimta Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Alimta Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 46. North America Alimta Sales by Country (2021-2026) & (kg) Table 47. North America Alimta Sales by Country (2027-2032) & (kg) Table 48. Europe Alimta Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 49. Europe Alimta Sales by Country (2021-2026) & (kg) Table 50. Europe Alimta Sales by Country (2027-2032) & (kg) Table 51. Asia Pacific Alimta Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 52. Asia Pacific Alimta Sales by Country (2021-2026) & (kg) Table 53. Asia Pacific Alimta Sales by Country (2027-2032) & (kg) Table 54. South America, Middle East and Africa Alimta Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 55. South America, Middle East and Africa Alimta Sales by Country (2021-2026) & (kg) Table 56. South America, Middle East and Africa Alimta Sales by Country (2027-2032) & (kg) Table 57. Global Alimta Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Alimta Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Alimta Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Alimta Revenue Market Share by Region (2021-2026) Table 61. Global Alimta Revenue Market Share by Region (2027-2032) Table 62. Eagle Pharmaceuticals Company Information Table 63. Eagle Pharmaceuticals Business Overview Table 64. Eagle Pharmaceuticals Alimta Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Eagle Pharmaceuticals Alimta Product Portfolio Table 66. Eagle Pharmaceuticals Recent Development Table 67. Eli Lilly Company Information Table 68. Eli Lilly Business Overview Table 69. Eli Lilly Alimta Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Eli Lilly Alimta Product Portfolio Table 71. Eli Lilly Recent Development Table 72. Cadila Healthcare Company Information Table 73. Cadila Healthcare Business Overview Table 74. Cadila Healthcare Alimta Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Cadila Healthcare Alimta Product Portfolio Table 76. Cadila Healthcare Recent Development Table 77. Abbott Healthcare Company Information Table 78. Abbott Healthcare Business Overview Table 79. Abbott Healthcare Alimta Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Abbott Healthcare Alimta Product Portfolio Table 81. Abbott Healthcare Recent Development Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. Alimta Distributors List Table 85. Alimta Customers List Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Alimta Product Image Figure 2. Global Alimta Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alimta Market Size (2021-2032) & (US$ Million) Figure 4. Global Alimta Sales (2021-2032) & (kg) Figure 5. Global Alimta Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Alimta Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg Image Figure 9. 500mg Image Figure 10. Global Alimta Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 11. Global Alimta Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Alimta Sales Market Share by Type (2021-2032) Figure 13. Global Alimta Revenue by Type (2021 VS 2025 VS 2032) & (kg) Figure 14. Global Alimta Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Alimta Revenue Market Share by Type (2021-2032) Figure 16. Pleural Mesothelioma Image Figure 17. Non-small Cell Lung Cancer Image Figure 18. Global Alimta Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 19. Global Alimta Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Alimta Sales Market Share by Application (2021-2032) Figure 21. Global Alimta Revenue by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Alimta Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Alimta Revenue Market Share by Application (2021-2032) Figure 24. North America Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 25. North America Alimta Sales Market Share by Country (2021-2032) Figure 26. U.S. Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 27. Canada Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 28. Mexico Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 29. Europe Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 30. Europe Alimta Sales Market Share by Country (2021-2032) Figure 31. Germany Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 32. France Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 33. U.K. Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 34. Italy Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 35. Netherlands Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 36. Asia Pacific Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 37. Asia Pacific Alimta Sales Market Share by Country (2021-2032) Figure 38. China Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 39. Japan Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 40. South Korea Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 41. Southeast Asia Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 42. India Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 43. Australia Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 44. South America, Middle East and Africa Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 45. South America, Middle East and Africa Alimta Sales Market Share by Country (2021-2032) Figure 46. Brazil Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 47. South Africa Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 48. Saudi Arabia Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 49. Turkey Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 50. Argentina Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 51. UAE Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 52. Egypt Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 53. Chile Alimta Sales and Growth Rate (2021-2032) & (kg) Figure 54. Global Alimta Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Alimta Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Alimta Revenue (2021-2032) & (US$ Million) Figure 57. North America Alimta Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Alimta Revenue (2021-2032) & (US$ Million) Figure 59. Europe Alimta Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Alimta Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Alimta Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Alimta Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Alimta Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Alimta Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Alimta Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 500mg
Applications
  • Pleural Mesothelioma
  • Non-small Cell Lung Cancer
Companies covered
  • Eagle Pharmaceuticals
  • Eli Lilly
  • Cadila Healthcare
  • Abbott Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alimta Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alimta Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Alimta Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Alimta Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Alimta Market Dynamics
  1. 2.1 Alimta Industry Trends
  2. 2.2 Alimta Industry Drivers
  3. 2.3 Alimta Industry Opportunities and Challenges
  4. 2.4 Alimta Industry Restraints
3 Alimta Market by Manufacturers
  1. 3.1 Global Alimta Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Alimta Sales by Manufacturers (2021-2026)
  3. 3.3 Global Alimta Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Alimta Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alimta Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Alimta Manufacturers, Product Type & Application
  7. 3.7 Global Alimta Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alimta Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alimta Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alimta Tier 1, Tier 2, and Tier 3
4 Alimta Market by Type
  1. 4.1 Alimta Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 500mg
  4. 4.2 Global Alimta Sales by Type
  5. 4.2.1 Global Alimta Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alimta Sales by Type (2021-2032)
  7. 4.2.3 Global Alimta Sales Market Share by Type (2021-2032)
  8. 4.3 Global Alimta Revenue by Type
  9. 4.3.1 Global Alimta Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alimta Revenue by Type (2021-2032)
  11. 4.3.3 Global Alimta Revenue Market Share by Type (2021-2032)
5 Alimta Market by Application
  1. 5.1 Alimta Application Introduction
  2. 5.1.1 Pleural Mesothelioma
  3. 5.1.2 Non-small Cell Lung Cancer
  4. 5.2 Global Alimta Sales by Application
  5. 5.2.1 Global Alimta Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Alimta Sales by Application (2021-2032)
  7. 5.2.3 Global Alimta Sales Market Share by Application (2021-2032)
  8. 5.3 Global Alimta Revenue by Application
  9. 5.3.1 Global Alimta Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Alimta Revenue by Application (2021-2032)
  11. 5.3.3 Global Alimta Revenue Market Share by Application (2021-2032)
6 Global Alimta Sales by Region
  1. 6.1 Global Alimta Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alimta Sales by Region (2021-2032)
  3. 6.2.1 Global Alimta Sales by Region (2021-2026)
  4. 6.2.2 Global Alimta Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alimta Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Alimta Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Alimta Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Alimta Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Alimta Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Alimta Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Alimta Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Alimta Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Alimta Revenue by Region
  1. 7.1 Global Alimta Revenue by Region
  2. 7.1.1 Global Alimta Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Alimta Revenue by Region (2021-2026)
  4. 7.1.3 Global Alimta Revenue by Region (2027-2032)
  5. 7.1.4 Global Alimta Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Alimta Revenue (2021-2032)
  8. 7.2.2 North America Alimta Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Alimta Revenue (2021-2032)
  11. 7.3.2 Europe Alimta Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Alimta Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Alimta Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Alimta Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Alimta Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eagle Pharmaceuticals
  2. 8.1.1 Eagle Pharmaceuticals Company Information
  3. 8.1.2 Eagle Pharmaceuticals Business Overview
  4. 8.1.3 Eagle Pharmaceuticals Alimta Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eagle Pharmaceuticals Alimta Product Portfolio
  6. 8.1.5 Eagle Pharmaceuticals Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Alimta Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Alimta Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Cadila Healthcare
  14. 8.3.1 Cadila Healthcare Company Information
  15. 8.3.2 Cadila Healthcare Business Overview
  16. 8.3.3 Cadila Healthcare Alimta Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cadila Healthcare Alimta Product Portfolio
  18. 8.3.5 Cadila Healthcare Recent Developments
  19. 8.4 Abbott Healthcare
  20. 8.4.1 Abbott Healthcare Company Information
  21. 8.4.2 Abbott Healthcare Business Overview
  22. 8.4.3 Abbott Healthcare Alimta Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Healthcare Alimta Product Portfolio
  24. 8.4.5 Abbott Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alimta Value Chain Analysis
  2. 9.1.1 Alimta Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alimta Production Mode & Process
  6. 9.2 Alimta Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alimta Distributors
  9. 9.2.3 Alimta Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst